Title | Biallelic Mutations in ADPRHL2, Encoding ADP-Ribosylhydrolase 3, Lead to a Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Ghosh, SG, Becker, K, Huang, H, Dixon-Salazar, T, Chai, G, Salpietro, V, Al-Gazali, L, Waisfisz, Q, Wang, H, Vaux, KK, Stanley, V, Manole, A, Akpulat, U, Weiss, MM, Efthymiou, S, Hanna, MG, Minetti, C, Striano, P, Pisciotta, L, De Grandis, E, Altmüller, J, Nürnberg, P, Thiele, H, Yis, U, Okur, TDerya, Polat, AIpek, Amiri, N, Doosti, M, Karimani, EGhayoor, Toosi, MB, Haddad, G, Karakaya, M, Wirth, B, van Hagen, JM, Wolf, NI, Maroofian, R, Houlden, H, Cirak, S, Gleeson, JG |
Journal | Am J Hum Genet |
Volume | 103 |
Issue | 3 |
Pagination | 431-439 |
Date Published | 2018 09 06 |
ISSN | 1537-6605 |
Abstract | ADP-ribosylation, the addition of poly-ADP ribose (PAR) onto proteins, is a response signal to cellular challenges, such as excitotoxicity or oxidative stress. This process is catalyzed by a group of enzymes referred to as poly(ADP-ribose) polymerases (PARPs). Because the accumulation of proteins with this modification results in cell death, its negative regulation restores cellular homeostasis: a process mediated by poly-ADP ribose glycohydrolases (PARGs) and ADP-ribosylhydrolase proteins (ARHs). Using linkage analysis and exome or genome sequencing, we identified recessive inactivating mutations in ADPRHL2 in six families. Affected individuals exhibited a pediatric-onset neurodegenerative disorder with progressive brain atrophy, developmental regression, and seizures in association with periods of stress, such as infections. Loss of the Drosophila paralog Parg showed lethality in response to oxidative challenge that was rescued by human ADPRHL2, suggesting functional conservation. Pharmacological inhibition of PARP also rescued the phenotype, suggesting the possibility of postnatal treatment for this genetic condition. |
DOI | 10.1016/j.ajhg.2018.07.010 |
Alternate Journal | Am. J. Hum. Genet. |
PubMed ID | 30100084 |
PubMed Central ID | PMC6128219 |
Grant List | UM1 HG008900 / HG / NHGRI NIH HHS / United States U54 HG003067 / HG / NHGRI NIH HHS / United States UL1 TR001863 / TR / NCATS NIH HHS / United States MR/K000608/1 / / Medical Research Council / United Kingdom R01 NS048453 / NS / NINDS NIH HHS / United States U54 HG006504 / HG / NHGRI NIH HHS / United States R01 NS052455 / NS / NINDS NIH HHS / United States T32 GM008666 / GM / NIGMS NIH HHS / United States / / Wellcome Trust / United Kingdom F31 HD095602 / HD / NICHD NIH HHS / United States G0601943 / / Medical Research Council / United Kingdom |